MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
about
A genetic view of laryngeal cancer heterogeneityPhosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival.Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma.Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.Analysis of related factors of surgical treatment effect on 215 patients with laryngeal cancer.EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties.Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinomaMAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
P2860
Q36972817-5375B797-BD7E-4C7B-BF29-68BA3618526CQ37362503-24DCEE5F-1AD7-4415-90F6-31E87C9E29EAQ37687113-B6F8198C-3A3D-4EE7-88D7-F9284B3B18CFQ38696829-94C84A0A-C066-4102-AA33-C52B5B00CE85Q47100472-0D09C7A8-C2D6-41E4-B266-94BDAC39E79AQ47122756-4FF35715-53FA-47D6-870A-4E3252277E88Q49875608-896DC70C-0E51-4A84-B96B-E69C9049E544Q53698558-EF6B4D4A-902D-4376-8A0C-63BB125607DCQ55227686-3B3FC4A0-8BF3-4411-9919-6FA192BFFC18Q55305474-80454C18-DC6A-4343-A703-D6133E829FFBQ58770545-DF106F72-0BEB-41A9-89AB-FFE6B835C0EEQ58779402-18963526-AD6E-4CA3-96CF-39D173DCD3FE
P2860
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
@ast
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
@en
type
label
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
@ast
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
@en
prefLabel
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
@ast
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.
@en
P2093
P2860
P356
P1433
P1476
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer
@en
P2093
David Chinchón
Jerónimo Pachón
José Luis López-Guerra
Manuel Chaves-Conde
María-José de Miguel-Luken
Sandra Muñoz-Galván
Verónica de Miguel-Luken
Vladimir Suarez
P2860
P304
12625-12636
P356
10.18632/ONCOTARGET.3470
P407
P577
2015-05-01T00:00:00Z